Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CardioVascular BioTherapeutics Inc.
DescriptionHuman fibroblast growth factor (FGF) inducer of angiogenesis
Molecular Target Fibroblast growth factor (FGF) receptor (FGFR)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDermal ulcers
Indication DetailsTreat chronic ischemic diabetic wounds; Treat diabetic or venous stasis ulcers
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today